Product ID: SQMIG35I2219
Report ID:
SQMIG35I2219 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
66 |
Figures:
75
In 2022, North America dominated the market and accounted for a revenue share of 40.0%. Due to the well-established healthcare sector in this business and the increased prevalence of respiratory illnesses, market share growth is predicted. The existence of multinational pharmaceutical and biotech corporations in the area, as well as increased investment in R&D operations, are other factors contributing to the growth of this region.
Asia Pacific is estimated to see an exponential CAGR during the anticipated time period due to rising healthcare expenses and the need for improved infrastructure for laboratory and clinical research. Additionally, it is anticipated that regulatory policies promoting improvements in biosafety quality would foster future growth potential in healthcare companies. The Indian government is putting various strategic initiatives into place to stimulate more research and innovation for the creation of new medications, which will spur market expansion.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35I2219